Literature DB >> 29111350

Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship.

Romana T Netea-Maier1, Johannes W A Smit2, Mihai G Netea3.   

Abstract

In order to adapt to the reduced availability of nutrients and oxygen in the tumor microenvironment and the increased requirements of energy and building blocks necessary for maintaining their high proliferation rate, malignant cells undergo metabolic changes that result in an increased production of lactate, nitric oxide, reactive oxygen species, prostaglandins and other byproducts of arachidonic acid metabolism that influence both the composition of the inflammatory microenvironment and the function of the tumor-associated macrophages (TAMs). In response to cues present in the TME, among which products of altered tumor cell metabolism, TAMs are also required to reprogram their metabolism, with activation of glycolysis, fatty acid synthesis and altered nitrogen cycle metabolism. These changes result in functional reprogramming of TAMs which includes changes in the production of cytokines and angiogenetic factors, and contribute to the tumor progression and metastasis. Understanding the metabolic changes governing the intricate relationship between the tumor cells and the TAMs represents an essential step towards developing novel therapeutic approaches targeting the metabolic reprogramming of the immune cells to potentiate their tumoricidal potential and to circumvent therapy resistance.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell metabolism; Immunometabolism; Tumor microenvironment; Tumor-associated macrophages

Mesh:

Substances:

Year:  2017        PMID: 29111350     DOI: 10.1016/j.canlet.2017.10.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  80 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

3.  Lipid Metabolism and Tumor Antigen Presentation.

Authors:  Hong Qin; Yaxi Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition.

Authors:  Christopher Ecker; James L Riley
Journal:  Cell Metab       Date:  2018-08-07       Impact factor: 27.287

Review 5.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

6.  Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS/HIF-1a/VEGF signaling pathway.

Authors:  Jie Zhang; Qian Wang; Qiang Wang; Peng Guo; Yong Wang; Yuqing Xing; Mengmeng Zhang; Fujun Liu; Qingyun Zeng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-26       Impact factor: 3.000

7.  Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.

Authors:  Ding Ma; Senquan Liu; Bachchu Lal; Shuang Wei; Shuyan Wang; Daqian Zhan; Hao Zhang; Richard S Lee; Peisong Gao; Hernando Lopez-Bertoni; Mingyao Ying; Jian Jian Li; John Laterra; Mary Ann Wilson; Shuli Xia
Journal:  Cancer Res       Date:  2019-03-21       Impact factor: 12.701

Review 8.  Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

9.  ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.

Authors:  Jun Lu; Zhan Chen; Hu Zhao; Huiyue Dong; Ling Zhu; Yi Zhang; Jie Wang; Hehuan Zhu; Qiang Cui; Chuang Qi; Shuiliang Wang; Shushang Chen; Jichun Shao
Journal:  J Transl Med       Date:  2020-02-24       Impact factor: 5.531

10.  Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors.

Authors:  Snehal Bindra; Marlon A McGill; Marina K Triplett; Anisha Tyagi; Premal H Thaker; Laila Dahmoush; Michael J Goodheart; R Todd Ogden; Edward Owusu-Ansah; Kalpita R Karan; Steve Cole; Anil K Sood; Susan K Lutgendorf; Martin Picard
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.